An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors

References

• RunowiczCDLeachCRHenryNLAmerican Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guidelineJ Clin Oncol201634661163526644543
   PubMed Web of Science ®Google Scholar
• WefelJSKeslerSRNollKRSchagenSBClinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsCA Cancer J Clin201565212313825483452
   PubMed Web of Science ®Google Scholar
• AhlesTARootJCRyanELCancer- and cancer treatment-associated cognitive change: an update on the state of the scienceJ Clin Oncol201230303675368623008308
   PubMed Web of Science ®Google Scholar
• AhlesTASaykinAJCandidate mechanisms for chemotherapy-induced cognitive changesNat Rev Cancer20077319220117318212
   PubMed Web of Science ®Google Scholar
• KoleckTAConleyYPIdentification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular levelBreast Cancer (Dove Med Press)20168293727022301
   PubMedGoogle Scholar
• KoleckTABenderCMSereikaSMApolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancerOncol Nurs Forum2014416E313E32525355028
   PubMed Web of Science ®Google Scholar
• AhlesTASaykinAJNollWWThe relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapyPsychooncology200312661261912923801
   PubMed Web of Science ®Google Scholar
• AhlesTALiYMcDonaldBCLongitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smokingPsychooncology201423121382139024789331
   PubMed Web of Science ®Google Scholar
• LengacherCAReichRRKipKEModerating effects of genetic polymorphisms on improvements in cognitive impairment in breast cancer survivors participating in a 6-week mindfulness-based stress reduction programBiol Res Nurs201517439340425882604
   PubMed Web of Science ®Google Scholar
• NgTTeoSMYeoHLBrain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancerNeuro Oncol201618224425126289590
   PubMed Web of Science ®Google Scholar
• SmallBJRawsonKSWalshECatechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivorsCancer201111771369137621425136
   PubMed Web of Science ®Google Scholar
• KoleckTABenderCMSereikaSMPolymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory studySpringerplus2016542227099827
   PubMedGoogle Scholar
• BenderCMMerrimanJDGentryALPatterns of change in cognitive function with anastrozole therapyCancer2015121152627263625906766
   PubMed Web of Science ®Google Scholar
• JerevallPLMaXJLiHPrognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trialBr J Cancer2011104111762176921559019
   PubMed Web of Science ®Google Scholar
• TuttAWangARowlandCRisk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signatureBMC Cancer2008833919025599
   PubMed Web of Science ®Google Scholar
• PaikSShakSTangGA multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerN Engl J Med2004351272817282615591335
   PubMed Web of Science ®Google Scholar
• PaikSTangGShakSGene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancerJ Clin Oncol200624233726373416720680
   PubMed Web of Science ®Google Scholar
• ParkerJSMullinsMCheangMCSupervised risk predictor of breast cancer based on intrinsic subtypesJ Clin Oncol20092781160116719204204
   PubMed Web of Science ®Google Scholar
• van’t VeerLJDaiHvan de VijverMJGene expression profiling predicts clinical outcome of breast cancerNature2002415687153053611823860
   PubMed Web of Science ®Google Scholar
• BuyseMLoiSvan’t VeerLValidation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancerJ Natl Cancer Inst200698171183119216954471
   PubMed Web of Science ®Google Scholar
• LehmannTPKorskiKIbbsMZawieruchaPGrodecka-GazdeckaSJagodzińskiPPrs12976445 Variant in the pri-miR-125a correlates with a lower level of hsa-miR-125a and ERBB2 overexpression in breast cancer patientsOncol Lett20135256957323420759
   PubMed Web of Science ®Google Scholar
• HuYLiuCMQiLTwo common SNPs in pri-miR-125a alter the mature miRNA expression and associate with recurrent pregnancy loss in a Han-Chinese populationRNA Biol20118586187221788734
   PubMed Web of Science ®Google Scholar
• BarzanDVeldwijkMRHerskindCComparison of genetic variation of breast cancer susceptibility genes in Chinese and German populationsEur J Hum Genet201321111286129223486537
   PubMed Web of Science ®Google Scholar
• HanJJiangTBaiHGenetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese populationBreast Cancer Res Treat2011129390190721528353
   PubMed Web of Science ®Google Scholar
• HeinRMaranianMHopperJLComparison of 6q25 breast cancer hits from Asian and European genome wide association studies in the Breast Cancer Association Consortium (BCAC)PLoS One201278e4238022879957
   PubMed Web of Science ®Google Scholar
• StevensKNVachonCMLeeAMCommon breast cancer susceptibility loci are associated with triple-negative breast cancerCancer Res201171196240624921844186
   PubMed Web of Science ®Google Scholar
• FletcherOJohnsonNOrrNNovel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association studyJ Natl Cancer Inst2011103542543521263130
   PubMedGoogle Scholar
• YuBLinHYangLGenetic variation in the Nrf2 promoter associates with defective spermatogenesis in humansJ Mol Med201290111333134222648520
   PubMed Web of Science ®Google Scholar
• MillerSADykesDDPoleskyHFA simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Res198816312153344216
   PubMed Web of Science ®Google Scholar
• DNA GenotekLaboratory protocol for manual purification of DNA from whole sample2015 Available from: http://www.dnagenotek.com/US/pdf/PD-PR-015.pdfAccessed December 14, 2016
   Google Scholar
• RobbinsTJamesMOwenASahakianBMcInnesLRabbittPCambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteersDementia1994552662817951684
   PubMedGoogle Scholar
• Lafayette Clinical Instruments CompanyLafayette Clinical Repeatable Neuropsychological BatterySagamore (IN)Lafayette Clinical Instruments Company1989
   Google Scholar
• DelisDCKaplanEKramerJHDelis-Kaplan (D-KEFS) Executive Function System, Examiners ManualSan AntonioPsychological Corporation2001
   Google Scholar
• KloveHClinical neuropsychologyMed Clin North Am1963471647165814078168
   PubMed Web of Science ®Google Scholar
• WechslerDThe Wechsler Memory Scale: Revised ManualSan AntonioPsychological Corporation1998
   Google Scholar
• ReyAL’examen psychologique dans les cas d’encephalopathie traumatique (les problems) [The psychological examination in cases of traumatic encephalopathy: problems]Arch Psychol194128215285 French
   Google Scholar
• CockburnJSmithPTCorrelates of everyday memory among residents of Part III homesBr J Clin Psychol199332Pt 175778467276
   PubMed Web of Science ®Google Scholar
• OsterriethPALe test de copie d’une figure complexe: contribution a l’etude de la perception et de la memoire [Test of copying a complex figure: contribution to the study of perception and memory]Arch Psychol194430206356 French
   Google Scholar
• NelsonHThe National Adult Reading Test (NART): Test ManualWindsor, UKNFER-Nelson1982
   Google Scholar
• BeckATSteerRABrownGKBeck Depression Inventory-IISan AntonioPsychological Corporation1996
   Google Scholar
• McNairDLorrMDropplemanLFEdITS Manual for the Profile of Mood States (POMS)San DiegoEducational and Industrial Testing Service1992
   Google Scholar
• CleelandCSMeasurement of pain by subjective reportChapmanCRLoeserJDAdvances in Pain Research and Therapy12New YorkRaven Press1989391403
   Google Scholar
• SundermannEEMakiPMBishopJRA review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognitionMenopause201017487488620616674
   PubMed Web of Science ®Google Scholar
• YaffeKLindquistKSenSEstrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC studyNeurobiol Aging200930460761417889406
   PubMed Web of Science ®Google Scholar
• BousmanCASzoekeCChenKDennersteinLHendersonVWEverallIPOestrogen alpha-receptor variant and two-year memory decline in midlife Australian womenNeuropsychobiology201266425926523128795
   PubMed Web of Science ®Google Scholar
• KravitzHMMeyerPMSeemanTEGreendaleGASowersMRCognitive functioning and sex steroid hormone gene polymorphisms in women at midlifeAm J Med20061199 Suppl 1S94S10216949394
   PubMed Web of Science ®Google Scholar
• YaffeKLuiLYGradyDStoneKMorinPEstrogen receptor 1 polymorphisms and risk of cognitive impairment in older womenBiol Psychiatry200251867768211955468
   PubMed Web of Science ®Google Scholar
• Yamamoto-IbusukiMYamamotoYFujiwaraSC6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patientsEur J Hum Genet201523794995625370037
   PubMed Web of Science ®Google Scholar
• HongYChenXQLiJYCurrent evidence on the association between rs3757318 of C6orf97 and breast cancer risk: a meta-analysisAsian Pac J Cancer Prev201415198051805525338983
   PubMedGoogle Scholar
• FletcherOJohnsonNOrrNNovel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association studyJ Natl Cancer Inst2011103542543521263130
   PubMedGoogle Scholar
• VeeraraghavanJTanYCaoXXRecurrent ESR1-CCDC170 rearrangements in an aggressive subset of estrogen-receptor positive breast cancersNat Commun201554577
   Web of Science ®Google Scholar
• BrintonRDThompsonRFFoyMRProgesterone receptors: form and function in brainFront Neuroendocrinol200829231333918374402
   PubMed Web of Science ®Google Scholar
• HendersonVWSt JohnJAHodisHNCognition, mood, and physiological concentrations of sex hormones in the early and late postmenopauseProc Natl Acad Sci U S A201311050202902029524277815
   PubMed Web of Science ®Google Scholar
• VoytkoMLMurrayRHiggsCJExecutive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesteroneJ Neurosci20092933103621037019692611
   PubMed Web of Science ®Google Scholar
• StenzigJSchweikertAPiaseckiAHöppnerGEschenhagenTRauTProgesterone receptor variants associated with the PROGINS haplotype exhibit functional properties similar to those of wild-type progesterone receptorPharmacogenet Genomics201222862964122722322
   PubMed Web of Science ®Google Scholar
• AgoulnikIUTongXWFischerDCA germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer riskJ Clin Endocrinol Metab200489126340634715579801
   PubMed Web of Science ®Google Scholar
• RockwellLCRoweEJArnsonKWorldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancersAm J Hum Biol2012241425122121098
   PubMed Web of Science ®Google Scholar
• LiuTChenLSunXProgesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studiesTumor Biol201435324272436
   Google Scholar
• RomanoADelvouxBFischerDCGroothuisPThe PROGINS polymorphism of the human progesterone receptor diminishes the response to progesteroneJ Mol Endocrinol2007381–233135017293450
   PubMed Web of Science ®Google Scholar
• LeeEHsuCHaimanCAGenetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approachCarcinogenesis20103181392139920547493
   PubMed Web of Science ®Google Scholar
• NCBI Resource CoordinatorsDatabase resources of the National Center for Biotechnology InformationNucleic Acids Res Epub20141114
   Web of Science ®Google Scholar
• Silvestre-RoigCFernándezPMansegoMLGenetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosisCirc Cardiovasc Genet201471597024395923
   PubMedGoogle Scholar
• WintersZEHuntNCBradburnMJSubcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer: association with prognosisEur J Cancer2001372405241211720835
   PubMed Web of Science ®Google Scholar
• KawamotoHKoizumiHUchikoshiTExpression of the G2-M checkpoint regulators cyclin B1 and Cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analysesAm J Pathol1997150115239006317
   PubMed Web of Science ®Google Scholar
• SilvaARSantosACFarfelJMRepair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer’s diseasePLoS One201496e9989724936870
   PubMed Web of Science ®Google Scholar
• SalaAB-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancerEur J Cancer200541162479248416198555
   PubMed Web of Science ®Google Scholar
• LuiDXNathNChellappanSPGreeneLARegulation of neuron survival and death by p130 and associated chromatin modifiersGenes Dev200519671973215769944
   PubMed Web of Science ®Google Scholar
• LiuDXBiswasSCGreeneLAB-Myb and C-Myb play required roles in neuronal apoptosis evoked by nerve growth factor deprivation and DNA damageJ Neurosci200424408720872515470138
   PubMed Web of Science ®Google Scholar
• IyirhiaroGOZhangYEsteyCRegulation of ischemic neuronal death by E2F4-p130 protein complexesJ Biol Chem201428926182021821324828495
   PubMed Web of Science ®Google Scholar
• SchwabRBussolariRCorvettaDIsolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer riskOncogene200827202929293318026132
   PubMed Web of Science ®Google Scholar
• AleskandaranyMASoriaDGreenARMarkers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratificationBreast Cancer Res Treat2015151232533325953687
   PubMed Web of Science ®Google Scholar
• LyngMBLænkholmAVTanQGene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyPLoS One201381e5407823342080
   PubMed Web of Science ®Google Scholar
• KerrDAWittliffJLA five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifenHorm Cancer20112526127121826535
   PubMedGoogle Scholar
• Abdel-FatahTMPoweDGBallGProposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancerJ Pathol2010222438839920922713
   PubMed Web of Science ®Google Scholar
• DawsonSJMakretsovNBlowsFMBCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedBr J Cancer2010103566867520664598
   PubMed Web of Science ®Google Scholar
• BremerTMJacquemierJCharafe-JauffretEViensPBirnbaumDLinkeSPPrognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patientsInt J Cancer2009124489690419035452
   PubMed Web of Science ®Google Scholar
• CallagyGMWebberMJPharoahPDCaldasCMeta-analysis confirms BCL2 is an independent prognostic marker in breast cancerBMC Cancer2008815318510726
   PubMed Web of Science ®Google Scholar
• LinkeSPBremerTMHeroldCDSauterGDiamondCA multi-marker model to predict outcome in tamoxifen-treated breast cancer patientsClin Cancer Res20061241175118316489071
   PubMed Web of Science ®Google Scholar
• BatchelderAJGordon-WeeksANWalkerRAAltered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breastsBreast Cancer Res Treat20091141636918368476
   PubMed Web of Science ®Google Scholar
• SloanCDShenLWestJDGenetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypesAm J Med Genet B Neuropsychiatr Genet2010153B51060106920468060
   PubMed Web of Science ®Google Scholar
• HohNZWagnerAKAlexanderSABCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injuryJ Neurotrauma20102781413142720504155
   PubMed Web of Science ®Google Scholar
• YuKDDiGHFanLA functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancerFASEB J20092372274228719228880
   PubMed Web of Science ®Google Scholar
• RoodiNDupontWDMooreJHParlFFAssociation of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer riskCancer Res20046441233123614973116
   PubMed Web of Science ®Google Scholar
• ReedDJGlutathione: toxicological implicationsAnnu Rev Pharmacol Toxicol1990306036312188580
   PubMed Web of Science ®Google Scholar
• HagerMHMorleySBielenbergDRDIAPH3 governs the cellular transition to the amoeboid tumour phenotypeEMBO Mol Med20124874376022593025
   PubMed Web of Science ®Google Scholar
• VorstmanJAvan DaalenEJalaliGRA double hit implicates DIAPH3 as an autism risk geneMol Psychiatry201116444245120308993
   PubMed Web of Science ®Google Scholar
• HornDZhouWTrevissonEThe conserved mitochondrial twin Cx9C protein Cmc2 is a Cmc1 homologue essential for cytochrome C oxidase biogenesisJ Biol Chem201028520150881509920220131
   PubMed Web of Science ®Google Scholar